Global Hemostasis Products Market will reach USD 5.30

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Global Hemostasis Products Market will reach USD 5.30 Billion By 2021: Zion Market Research

Sarasota, FL, Dec. 12, 2016 (GLOBE NEWSWIRE) -- Zion Research has published a new report titled “Hemostasis Products Market (Topical Hemostasis, Infusible Hemostasis, and Advanced Hemostasis) for Trauma, Surgery, Hemophilia, Myocardial Infarction, Stroke, and Thrombosis Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021” . According to the report, the global  hemostasis products market  was valued at approximately USD 5.30 billion in 2015 and is expected to reach approximately USD 6.70 billion by 2021, growing at a CAGR of around 4.0% between 2016 and 2021.

Hemostasis is a process which helps to cease the bleeding and keep blood within a damaged blood vessel. Hemostasis products are medical products used to stop bleeding and hemorrhage caused by injuries and surgical procedures. These products vary based on their mechanism of action, ease of application, composition, immunogenicity, adherence to tissue, and cost.

Browse through 27 Market Tables and 18 Figures spread over 110 Pages and in-depth TOC on “Global Hemostasis Products Market: By Product, Application, Industry Size, Share, Trends, Segment, Analysis, and Forecast 2015-2021”.

Request free Sample copy of Hemostasis Products Market Report @ https://www.zionmarketresearch.com/sample/hem...cts-market

The hemostasis product market is anticipated to witness noticeable growth over the next six years on account of growing demand supported by rising surgery volumes. Moreover, rapid growth in geriatric population base and rising prevalence of chronic conditions are other impacts rendering drivers of hemostasis product market. According to the CDC statistics, more than 45% of the American population suffers from at least one chronic condition requiring important care. However, slow adoption of advanced hemostasis instruments in emerging economies and the high cost of devices may curb the market growth in the near future.

Nonetheless, emerging market in developing countries is expected to open up new growth avenues within the forecast period. Some of the key product in this market includes topical hemostasis, infusible hemostasis, and advanced hemostasis. The topical hemostats are further classified into collagen, oxidized regenerated cellulose, gelatin, and polysaccharide. Infusible hemostasis includes platelet concentrates from donor blood, FVIII derived from blood, fresh frozen plasma, and prothrombin complex. Topical hemostats were the leading segment and it accounted for significant share of total revenue generated in 2015. Topical hemostats are generally used in adjunction with conventional treatment to provide minimal tissue reactivity, quick and easy absorbability of the hemostatic agent, non-antigenicity, and cost-efficiency. Infusible hemostasis and advanced hemostasis are expected to witness exponential growth over the forecast period.

Browse the full " Hemostasis Products Market (Topical Hemostasis, Infusible Hemostasis, and Advanced Hemostasis) for Trauma, Surgery, Hemophilia, Myocardial Infarction, Stroke, and Thrombosis Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021 " report at  https://www.zionmarketresearch.com/report/hem...cts-market

Based on application, the market can be segmented into trauma, surgery, hemophilia, myocardial infarction, stroke, and thrombosis. Bleeding control is an important aim in surgery. Surgery and trauma are expected to be the fastest-growing segment. More than 80% of trauma deaths that occur in the operating room do so as a result of hemorrhage. Traumatic injury is a major global health problem, accounting for approximately 1 in 10 deaths worldwide.

North America region dominated the overall hemostasis products market and this region accounted for the largest share of the market in terms of revenue in 2015. This trend is expected to continue in the years to come. Increasing healthcare expenditure and technological advancement to provide innovative products are expected to drive the market growth in the near future. Thus, this region is expected to witness a significant growth in the hemostasis products market within the forecast period.

Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/he...cts-market

Asia Pacific is expected to be a lucrative market over the next few years on account of increased medical tourism and surgical procedures. Furthermore, hemostasis products market has the huge opportunity in the emerging markets of Asia Pacific due to the increasing aging population, rising health awareness and increasing investment in the healthcare sector especially in China and India. 

Europe was another leading regional hemostasis products market in 2015. Europe hemostasis products market is expected to be driven due to the rise in geriatric population base, which is expected to ultimately lead to higher number of surgeries. Moreover, growth in this region is attributed to increasing concern regarding health among people.

Request a customized copy of report @ https://www.zionmarketresearch.com/custom/471

The Middle East & Africa is expected to witness the significant growth in coming years. The rapid growth of hemostasis products market will be driven by the increasing healthcare awareness coupled with advancement in technology. Latin America is another important regional market and is expected to experience significant growth over the forecast period. The growth is mainly due to the increasing demand for soft tissue repair treatment coupled with technological advancement. Thus, all aforementioned parameters are expected to propel the market growth in this region.

Some of the key players in the market such as Pfizer, Inc., Medtronic plc, Abbott Laboratories, Johnson & Johnson, Integra LifeSciences Corporation, HemCon Medical Technologies, Inc., Grifols, S.A.,  CSL Behring LLC, C. R. Bard, Inc. and Baxter International, Inc.

Purchase a direct copy of report with TOC @ https://www.zionmarketresearch.com/buynow/su/...cts-market

This report segments the global hemostasis products market as follows: Global Hemostasis Products Market: Product Segment Analysis

  • Topical Hemostasis
    • Collagen
    • Oxidized Regenerated Cellulose
    • Gelatin
    • Polysaccharide
  • Infusible Hemostasis
    • Platelet Concentrates from Donor Blood
    • FVIII Derived from Blood
    • Fresh Frozen Plasma
    • Prothrombin Complex
  • Advanced Hemostasis
    • Flowable
    • Thrombin
    • Fibrin
    • Synthetic Sealants

Global Hemostasis Products Market: Application Segment Analysis

  • Trauma
  • Surgery
  • Hemophilia
  • Myocardial Infarction
  • Stroke
  • Thrombosis

Global Hemostasis Products Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • Germany
    • France
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East & Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research

Follow Us Twitter: https://twitter.com/zion_research

Contact Us: Joel John 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 27

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 182

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 110

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 247

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 116

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 351

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 0

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 197

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

b1BANK Partners with Spiral to Enhance Community Banking Impact

Updated Category News Views 97

Enhanced Financial Wellness through Partnership NEW YORK--Today, Spiral, a personalized banking platform, announced a significant partnership with b1BANK, established as a community-focused banking institution. Through this collaboration, the two organizations aim to enhance financial wellness for customers, leveraging b1BANK's dedication to innovative banking solutions...

Continue Reading
AM Best Explores Trends Influencing For-Hire Trucking Industry

Updated Category News Views 168

Insights from AM Best's Latest Webinar on Trucking Trends Viewers can now delve into the highlights from the enlightening webinar hosted by AM Best, titled "For-Hire Trucking: The Risky Road Ahead." This event focused on the intricacies and challenges within the transportation-for-hire trucking sector, providing expert insights into risk management strategies and the...

Continue Reading
BitMart's Creative Campaign to Ignite Offline Crypto Engagement

Updated Category News Views 135

Introducing the Fox Hunt Delivery Campaign BitMart, a leading global cryptocurrency exchange, is excited to announce the launch of the Fox Hunt Delivery Campaign, a unique initiative aimed at boosting cryptocurrency adoption through engaging offline activities. This campaign offers an exciting chance for participants to earn USDT rewards simply by introducing new users to...

Continue Reading
Trinity Capital Inc. Fuels Alt Platform's Growth with $40M Credit

Updated Category News Views 273

Trinity Capital Inc. Supports Alt with Significant Credit Facility Trinity Capital Inc. (NASDAQ: TRIN), a prominent alternative asset manager, is thrilled to announce a groundbreaking agreement with Alt, providing up to $40 million through an asset-based revolving credit facility. This funding aims to bolster Alt's innovative marketplace tailored for trading card...

Continue Reading
Everest Medicines Achieves Record Revenue and Growth in 2024

Updated Category News Views 506

Everest Medicines Achieves Remarkable Financial Success Everest Medicines, a groundbreaking biopharmaceutical company focused on innovative healthcare solutions, has reported remarkable financial results for the year ending December 31, 2024. With a robust revenue growth of 461%, the company stands out in the pharmaceutical industry, showcasing its resilience and dynamic...

Continue Reading